Table 2.
Modified surgical treatment score based on the revised Tokuhashi score for patients with lung cancer metastases to the spine
| Prognostic factor | Points | No. of patients |
|---|---|---|
| General condition (performance status) | ||
| Poor (PS 10–40%) | 0 | 23 |
| Moderate (PS 50–70%) | 1 | 45 |
| Good (PS 80–100%) | 2 | 52 |
| No. of extraspinal bone metastases | ||
| ≥ 3 | 0 | 34 |
| 1–2 | 1 | 25 |
| 0 | 2 | 61 |
| No. of metastases in the vertebral body | ||
| ≥ 3 | 0 | 63 |
| 2 | 1 | 20 |
| 1 | 2 | 37 |
| Metastases to the major internal organs | ||
| Unremovable | 0 | 21 |
| Removable | 1 | 2 |
| No metastases | 2 | 97 |
| Primary site of cancer | ||
| Lung | 0 | 120 |
| Palsy | ||
| Complete (Frankel A B) | 0 | 5 |
| Incomplete (Frankel C D) | 1 | 83 |
| None (Frankel E) | 2 | 32 |
| Tumor markers | ||
| Abnormal | 1 | 79 |
| Normal | 2 | 41 |
| Adoption of targeted therapy | ||
| Without | 1 | 72 |
| With | 2 | 48 |
| Prognostic groups | Total points | |
| Group A | 0–8 | 58 |
| Group B | 9–14 | 62 |